IR
55
-6
AXP
63
3
MRO
59
-3
EMN
52
-4
PSX
30
-2
SEE
49
3
MAC
62
-3
XRAY
22
2
FLS
67
4
FLR
59
4
ABBV
59
-3
HPE
53
3
FITB
52
-4
PBI
32
-3
DGX
39
-4
DTE
45
-2
PNW
60
-6
ES
53
-2
CAH
47
15
ZTS
36
7
IR
55
-6
AXP
63
3
MRO
59
-3
EMN
52
-4
PSX
30
-2
SEE
49
3
MAC
62
-3
XRAY
22
2
FLS
67
4
FLR
59
4
ABBV
59
-3
HPE
53
3
FITB
52
-4
PBI
32
-3
DGX
39
-4
DTE
45
-2
PNW
60
-6
ES
53
-2
CAH
47
15
ZTS
36
7
Financhill
Back

OptimizeRx 10K Form

Sell
13

OPRX
OptimizeRx

Last Price:
5.21
Seasonality Move:
13.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-05 10Q OPRX/OptimizeRx Quarterly
2020-05-06 10Q OPRX/OptimizeRx Quarterly
2020-03-26 10K OPRX/OptimizeRx Annual
2019-11-05 10Q OPRX/OptimizeRx Quarterly
2019-08-07 10Q OPRX/OptimizeRx Quarterly
2019-05-08 10Q OPRX/OptimizeRx Quarterly

Receive OPRX News And Ratings

See the #1 stock for the next 7 days that we like better than OPRX

OPRX Financial Statistics

Sales & Book Value

Annual Sales: $71.52M
Cash Flow: $697K
Price / Cash Flow: 0
Annual Sales: $6.61
Price / Book: 0.78

Profitability

EPS (TTM): -1.01000
Net Income (TTM): $-17.91M
Gross Margin: $42.9M
Return on Equity: -14.88%
Return on Assets: -11.52%

OptimizeRx Earnings Forecast

Key OptimizeRx Financial Ratios

  • The Gross Profit Margin over the past 17 years for OPRX is 59.98%.
  • The Selling, General & Administrative Expenses for OPRX have been equal to 81.12% of Gross Profit Margin.
  • The Research & Development expenses have been 2.49% of Revenue.
  • The Interest Expense is -8.28% of Operating Income.
  • The Net Earning history of OPRX is -24.56% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 7 years.

OptimizeRx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: OPRX
CUSIP: 68401U
Website: optimizerx.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 3.07
Quick Ratio: 2.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 11.23

OPRX Technical Analysis vs Fundamental Analysis

Sell
13
OptimizeRx (OPRX) is a Sell

Is OptimizeRx a Buy or a Sell?

  • OptimizeRx stock is rated a Sell
    The current OptimizeRx [OPRX] share price is $5.15. The Score for OPRX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.